The main problem in cancer therapy is that every patient and every tumor is different and reacts differently to drugs. Even worse, tumor cells rapidly change their response to drugs over time and develop resistances. What is needed is a system allowing to test which drug or drug combination works best on the tumor cells of a given patient at a given point in time. This is exactly the concept of TheraMe! We use microfluidic technology (a kind of miniaturized laboratory on a chip) to determine the best therapy options directly on live tumor samples from patients.
By using proprietary microfluidic technology we can run many drug tests directly on the tumor cells from patient biopsies or tumor resections. Instead of using conventional test tubes or microtiter plates, which require more cells for drug screens than what can be obtained from a patient, we perform drug tests in microscopic droplets inside microfluidic systems.
Route de la Corniche 5